Analysis of survival and objective response (OR) in patients with hepatocellular carcinoma in a phase III study of lenvatinib (REFLECT).

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 37, Issue 4_suppl, Pages 186-186

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2019-01-30

DOI

10.1200/jco.2019.37.4_suppl.186

Explore over 38,000 international journals covering a vast array of academic fields.

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now